We are live on ! Find out more
FRLN

Freeline Therapeutics Holdings plc American Depositary Shares
FRLN

Delisted

FRLN was delisted on the 16th of February, 2024.

Back to rankings

15 hedge funds and large institutions have $16.9M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less capital invested

Capital invested by funds: $18.2M → $16.9M (-$1.29M)

12% less funds holding

Funds holding: 17 → 15 (-2)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
3
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$70.2K
2
Citadel Advisors
Citadel Advisors
Florida
+$48.1K
3
Renaissance Technologies
Renaissance Technologies
New York
+$17.7K
4
VF
Virtu Financial
New York
+$8.62K

Top Sellers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
-$630K
2
CA
CHI Advisors
New York
-$44K
3
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$37K
4
Federated Hermes
Federated Hermes
Pennsylvania
-$29.9K
5
HCA
Harbor Capital Advisors
Illinois
-$11.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
SP
1
Syncona Portfolio
Guernsey
$10.1M – – –
EAM
2
Eventide Asset Management
Massachusetts
$2.16M -$630K -81,209 -21%
CA
3
CHI Advisors
New York
$2.15M -$44K -5,666 -2%
TAM
4
TFG Asset Management
Cayman Islands
$1.82M – – –
UBS Group
5
UBS Group
Switzerland
$228K -$8.76K -1,129 -3%
Renaissance Technologies
6
Renaissance Technologies
New York
$105K +$17.7K +2,280 +17%
Morgan Stanley
7
Morgan Stanley
New York
$86.2K -$978 -126 -1%
Millennium Management
8
Millennium Management
New York
$75K +$70.2K +9,045 +511%
Citadel Advisors
9
Citadel Advisors
Florida
$53.7K +$48.1K +6,202 +392%
HCA
10
Harbor Capital Advisors
Illinois
$49.6K -$11.1K -1,429 -17%
Two Sigma Investments
11
Two Sigma Investments
New York
$19.6K -$310 -40 -1%
OAMG
12
Odey Asset Management Group
United Kingdom
$13.7K – – –
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$12K – – –
VF
14
Virtu Financial
New York
$8K +$8.62K +1,111 New
APC
15
Aspire Private Capital
North Carolina
$546 – – –
Thrivent Financial for Lutherans
16
Thrivent Financial for Lutherans
Minnesota
– -$37K -5,260 Closed
Federated Hermes
17
Federated Hermes
Pennsylvania
– -$29.9K -4,000 Closed

FRLN Hedge Fund Activity: Q1 2023 in Review

15 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q1 2023, worth a combined $16.9M — down 7.1% from $18.2M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of FRLN and 1 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 3 added.

The largest buyer was Millennium Management, adding an estimated $70.2K. The largest seller was Eventide Asset Management, cutting an estimated $630K.

  • 15 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q1 2023, down from 17 in Q4 2022.
  • Funds reported $16.9M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q1 2023, down 7.1% quarter-over-quarter.
  • 1 fund opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q1 2023 and 3 closed out, a net change of -2 holders.
  • The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q1 2023 was Millennium Management, an estimated $70.2K added.
  • The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q1 2023 was Eventide Asset Management, an estimated $630K sold.

Based on aggregated 13F filings for Q1 2023.